The totality of evidence approach in the development of AVT02 (adalimumab), a biosimilar to Humira
Article in Therapeutic Advances in Chronic Disease (January 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Characterizing the kinetics of presepsin and associated inflammatory biomarkers in human endotoxemia
Article in Inflammation Research (July 2022)
CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production
Article in Arthritis Research & Therapy (January 2022)